Drivers and barriers to patient participation in RCTs

British Journal of Cancer

Volumn 108, Issue 7, 2013, Pages 1402-1407

  Jenkins, V ^a   Farewell, V ^b   Farewell, D ^c   Darmanin, J ^d   Wagstaff, J ^d   Langridge, C ^a   Fallowfield, L ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d NISCHR Clinical Research Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALTRUISM; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GYNECOLOGIC CANCER; HEALTH CARE PERSONNEL; HEMATOLOGIC MALIGNANCY; HUMAN; INFORMATION DISSEMINATION; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT PARTICIPATION; PATIENT SATISFACTION; PATIENT SELECTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CONCEPT; TREATMENT DURATION; TRUST; URINARY TRACT CANCER;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; PATIENT SELECTION; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84876481344     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.113     Document Type: Article

References (12)

1. Buss MK, DuBenske LL, Dinauer S, Gustafson DH, McTavish F, Cleary JF (2008) Patient/caregiver influences for declining participation in supportive oncology trials. J Suppor Oncol 6(4): 168-174. (Pubitemid 351586805)
2. Catt S, Langridge C, Fallowfield L, Talbot DC, Jenkins V (2011) Reasons given by patients for participating, or not, in Phase 1 cancer trials. EJC 47(10): 1490-1497.
3. Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, Siegler M (1995) Perceptions of cancer patients and their physicians involved in phase I trials. JCO 13(5): 1062-1072.
4. Fallowfield LJ, Jenkins VA, Brennan C, Sawtell M, Moynihan C, Souhami RL (1998) Patients' attitudes to randomised clinical trials of cancer therapy. EJC 34(10): 1554-1559. (Pubitemid 28446336)
5. Fallowfield LJ, Solis-Trapala I, Jenkins VA (2012) Evaluation of an educational program to improve communication with patients about early phase trial participation. Oncologist 17(7): 377-383.
6. Ford E, Jenkins V, Fallowfield L, Stuart N, Farewell D, Farewell V (2011) Clinicians' attitudes towards clinical trials of cancer therapy. BJC 104(10): 1535-1543.
7. Garcea G, Lloyd T, Steward WP, Dennison AR, Berry DP (2005) Differences in attitudes between patients with primary colorectal cancer and patients with secondary colorectal cancer: is it reflected in their willingness to participate in drug trials? EJCC 14(2): 166-170. (Pubitemid 40655735)
8. Jenkins V, Fallowfield L (2001) Reasons for accepting or declining to participate in randomised clinical trials for cancer therapy. BJC 82(11): 1783-1788.
9. Jenkins V, Farewell D, Batt L, Maughan T, Branston L, Langridge C, Parlour L, Farewell V, Fallowfield LJ (2010) The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. BJC 103: 1801-1807.
10. Locock L, Smith L (2011) Personal benefit, or benefiting others? Deciding whether to take part in clinical trials. Clin Trials 8(1): 85-93.
11. McCann SK, Campbell MK, Entwistle VA, Smith D (2010) Reasons for participating in randomised controlled trials: conditional altruism and considerations for self. Trials 11, art. no 31.
12. Penman DT, Holland JC, Bahna GF, Morrow G (1984) Informed consent for investigational chemotherapy: patients' and physicians' perceptions. JCO 2: 849-855. (Pubitemid 14050695)